Key result
Metabolic and bariatric surgery is associated with a substantial and sustained decrease in body weight and a significant reduction of cardiovascular risk factors.
Why the study?
CVD is the leading cause of mortality, obesity is a recognized risk factor, and early detection and management are critical to reduce risk in patients with obesity and related risk factors.
Does metabolic and bariatric surgery reduce cardiovascular risk in patients with obesity?
Does metabolic and bariatric surgery reduce cardiovascular risk in patients with obesity?
Metabolic and bariatric surgery leads to substantial weight loss and significant reduction in cardiovascular risk factors in patients with obesity.
May support bariatric surgery referral in obese patients with CVD risks; leaves open confirmation in randomized trials.
Cardiovascular disease (CVD) is the world's leading cause of mortality and obesity is a well-recognized risk factor of CVD. Early detection and management of CVD is critical to reduce CVD risk. Especially in patients suffering from obesity with obesity-related CVD risk factors such as hypertension (HTN), dyslipidemia, and diabetes mellitus (DM). A substantial and sustained decrease in body weight after metabolic and bariatric surgery is associated with a significant reduction of cardiovascular risk factors. This article reviews CVD risk models, mechanisms of CVD risk associated with obesity, and overall CVD risk reduction between different metabolic and bariatric procedures.
No takes yet. Share an insight, caveat, or question.
English et al. (2020) conducted a review in Cardiovascular disease and obesity. Metabolic and bariatric surgery was evaluated on Cardiovascular risk reduction. Metabolic and bariatric surgery is associated with a substantial and sustained decrease in body weight and a significant reduction of cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: